Holen Sie sich die Stockscreener-App
8.35
2.68%
-0.23
Handel nachbörslich:
8.31
-0.04
-0.48%
Schlusskurs vom Vortag:
$8.58
Offen:
$8.56
24-Stunden-Volumen:
6.41M
Relative Volume:
1.26
Marktkapitalisierung:
$1.30B
Einnahmen:
$2.59B
Nettoeinkommen (Verlust:
$-981.73M
KGV:
-1.4471
EPS:
-5.77
Netto-Cashflow:
$206.95M
1W Leistung:
+10.30%
1M Leistung:
+21.54%
6M Leistung:
-12.29%
1J Leistung:
-11.17%
1-Tages-Spanne:
$8.31
$8.625
1-Wochen-Bereich:
$7.5497
$8.93
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
2 MANHATTANVILLE ROAD, PURCHASE, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.35 | 1.30B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
282.61 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
59.18 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
59.31 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
101.28 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.67 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc Health, Inc.'s (NYSE:TDOC) Low P/S No Reason For Excitement - simplywall.st
Strong Option Activity Observed in Teladoc (TDOC) | TDOC Stock News - GuruFocus
Digital Therapeutics Market: Opportunities in Mental Health - openPR.com
Teladoc (TDOC) Rises Higher Than Market: Key Facts - Yahoo Finance
mHealth Ecosystem Market Hits New High | Major Giants- Teladoc Health, Cisco Systems, Google - openPR.com
Teladoc (TDOC) Sees Surge in Call Options Activity | TDOC Stock News - GuruFocus
Emerging Trends in Direct-to-Consumer Medical Services Market - openPR.com
Telehealth and Telemedicine Market Generated Opportunities, - openPR.com
AI-powered Telemedicine Market Generated Opportunities, - openPR.com
Upcoming Opportunities in Virtual Medical Appointment Market: - openPR.com
M&A to play ‘important role’ at Teladoc: CEO - Healthcare Dive
(TDOC) Long Term Investment Analysis - news.stocktradersdaily.com
Robust Growth in Future-Focused Patient Engagement Solutions - openPR.com
Teladoc at Goldman Sachs Conference: Strategic Focus on Growth - Investing.com Australia
Transcript : Teladoc Health, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 09 - MarketScreener
Incredible Growth of Remote Healthcare Support Solutions - openPR.com
Urgent Care Apps Market Set to Experience Telemedicine - openPR.com
Telehealth Services Market Is Booming So Rapidly 2025-2032 - openPR.com
DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To Know - Yahoo Finance
Telepsychiatry Market Future Business Opportunities - openPR.com
Lucet to Acquire Home Care Company Emcara Health - Dealbreaker
HIMS' Buyouts Fuel International Expansion & Digital Health Innovation - TradingView
Telepsychiatry Market Set to Witness Significant Growth by 2033 - openPR.com
Telestroke Services Market Is Booming So Rapidly 2025-2032 - openPR.com
Teladoc Health to Participate in Upcoming Investor Conference | - GuruFocus
Teladoc Health to Participate in Upcoming Investor Conference | TDOC Stock News - GuruFocus
Teladoc Health to Participate in Upcoming Investor Conference - GlobeNewswire
Virtual Care Leader Teladoc Takes Center Stage at Goldman Sachs Healthcare Conference - Stock Titan
Smart Telehealth Market Is Booming Worldwide 2025-2032 | Teladoc Health, Inc., American Well Corporation - openPR.com
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | TDOC Stock News - GuruFocus
Doximity Rides on Telehealth Demand: Will This Drive Sales Further? - sharewise
Business Opportunities in Asia-Pacific's USD 215.5 Billion Telemedicine Market, 2033 - GlobeNewswire
Telehealth Solutions Market 2025 | Growth Trends, Virtual Care, - openPR.com
Province ends virtual doctor pilot in Sussex hospital - Telegraph-Journal
Teladoc Health Executives Sell Shares - TradingView
Teladoc Health Announces Employee Inducement Awards under NYSE R - GuruFocus
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - The Manila Times
Teladoc Awards New Hires Massive 80,000-Share Stock Package Under NYSE Rule 303A.08 - Stock Titan
Ovatient Launches Virtual-First Care Offering at MUSC Health - Healthcare Innovation
Digital Healthcare Market Set to Witness Technology-Driven - openPR.com
Which Telehealth Stock Should You Be Targeting? - Schaeffer's Investment Research
Current and Future Analysis of Cost-Effective Medical Services - openPR.com
How the (TDOC) price action is used to our Advantage - news.stocktradersdaily.com
Why Is Teladoc (TDOC) Down 0.1% Since Last Earnings Report? - sharewise
Teladoc (TDOC) Sees Surge in Bullish Options Activity | TDOC Sto - GuruFocus
Empowering Growth: Virtual Patient Interaction Solutions - openPR.com
AI Diagnostics Telehealth Platforms Market Generated - openPR.com
Teladoc Health (TDOC) Target Price Lowered by B of A Securities | TDOC Stock News - GuruFocus
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Teladoc Health Inc-Aktie (TDOC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rodrigues Fernando M. | President of BetterHelp |
Jun 02 '25 |
Sale |
6.86 |
2,358 |
16,176 |
4,174 |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY |
Jun 02 '25 |
Sale |
6.86 |
5,808 |
39,843 |
69,773 |
| Bliss Kelly | President, U.S. Group Health |
Jun 02 '25 |
Sale |
6.86 |
4,653 |
31,920 |
50,266 |
| Murthy Mala | CHIEF FINANCIAL OFFICER |
Jun 02 '25 |
Sale |
6.86 |
13,856 |
95,052 |
132,443 |
| Nueno Carlos | President, International |
Jun 02 '25 |
Sale |
6.86 |
3,958 |
27,152 |
17,645 |
1.70%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):